×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS03 Considering Benefit-Risk Assessment in New Drug Applications
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor, Department of Clinical Medicine (Pharmaceutical Medicine)
Kitasato University School of Pharmacy , Japan
Speaker(s)
Katsuhiko Ichimaru
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of New Drug IV
Yuko Asahara
Novartis Pharma K.K., Japan
Global Drug Development Div, Regulatory Writing and Submissions, Head
Mamoru Narukawa, PhD, RPh
Kitasato University School of Pharmacy , Japan
Professor, Department of Clinical Medicine (Pharmaceutical Medicine)
Have an account?